A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol.
A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol.
复制标题
DOI：
10.1186/s12889-021-12015-w
复制
发表时间：
2021-10-29
影响因子：
4.5
通讯作者：
Schnall R
中科院分区：
文献类型：
--
作者：
Wood OR;Garofalo R;Kuhns LM;Scherr TF;Zetina APM;Rodriguez RG;Nash N;Cervantes M;Schnall R
美国感染艾滋病毒的青年人数继续上升，种族、族裔和性别的少数族裔青年，包括男男性行为者(YMSM)和年轻的变性人妇女(YTGW)，在艾滋病毒流行中承担了不成比例的负担。由于社会和医疗保健系统的因素，许多YMSM和YTGW不寻求艾滋病毒检测服务，因此不太可能意识到自己被感染了。移动卫生技术(MHealth)有能力增加这些人群中艾滋病毒检测的接受度。因此，mLab App-它将艾滋病毒预防信息与手机成像功能相结合，用于解释家里的艾滋病毒检测结果-是为了提高检测率，并在居住在纽约和芝加哥及其周边地区的黑人、拉丁裔和其他YMSM和YTGW之间建立联系。本研究是一项三臂随机对照试验，研究对象为18~29岁 的青壮年男童和青壮年育龄妇女。参与者被随机分配到mLab App干预组，其中包括艾滋病毒家庭检测试剂盒和预防护理标准，或仅限于预防护理标准，或仅艾滋病毒家庭检测试剂盒和预防护理标准。用于艾滋病毒预防的移动健康技术能够实时提供干预措施，这为远程接触全国各地的用户创造了机会，以加强他们的艾滋病毒护理连续参与和治疗结果。特别是在新冠肺炎大流行期间，移动健康技术与家庭检测相结合可能被证明是提高艾滋病毒检测率的关键，特别是在高危人群或无法定期获得艾滋病毒检测的人群中。该试验于2019年1月14日在ClinicalTrials.gov(NCT03803683)注册。
The number of youth living with HIV in the United States (US) continues to rise, and racial, ethnic, and sexual minority youth including young men who have sex with men (YMSM) and young transgender women (YTGW) bear a disproportionate burden of the HIV epidemic. Due to social and healthcare system factors, many YMSM and YTGW do not seek HIV testing services and are therefore less likely to be aware that they are infected. Mobile health technology (mHealth) has the ability to increase uptake of HIV testing among these populations. Thus, the mLab App—which combines HIV prevention information with a mobile phone imaging feature for interpreting at-home HIV test results—was developed to improve testing rates and linkage to care among Black, Latino, and other YMSM and YTGW living in New York City and Chicago and their surrounding areas. This study is a three-arm randomized controlled trial among YMSM and YTGW aged 18–29 years. Participants are randomized to either the mLab App intervention including HIV home test kits and standard of preventive care, standard of preventive care only, or HIV home test kits and standard of preventive care only. mHealth technology used for HIV prevention is capable of delivering interventions in real-time, which creates an opportunity to remotely reach users across the country to strengthen their HIV care continuum engagement and treatment outcomes. Specifically during the COVID-19 pandemic, mHealth technology combined with at-home testing may prove to be essential in increasing HIV testing rates, especially among populations at high-risk or without regular access to HIV testing. This trial was registered with Clinicaltrials.gov (NCT03803683) on January 14, 2019.
登录
查看更多内容
DOI：
10.1097/qai.0000000000001084
发表时间：
2016-08-15
期刊：
Journal of acquired immune deficiency syndromes (1999)
影响因子：
--
作者：
Garofalo R;Kuhns LM;Reisner SL;Mimiaga MJ
通讯作者：
Mimiaga MJ
影响因子：
3.1
作者：
Carnevale C;Richards P;Cohall R;Choe J;Zitaner J;Hall N;Cohall A;Whittier S;Green DA;Sobieszczyk ME;Gordon P;Zucker J
通讯作者：
Zucker J
DOI：
10.2174/1874613620130812003
发表时间：
2013
期刊：
The open AIDS journal
影响因子：
--
作者：
Catalani C;Philbrick W;Fraser H;Mechael P;Israelski DM
通讯作者：
Israelski DM
高风险年轻人使用艾滋病毒自我测试的信息，动机和行为技巧。
影响因子：
4.4
作者：
Brown W 3rd;Carballo-Diéguez A;John RM;Schnall R
通讯作者：
Schnall R
影响因子：
120.7
作者：
Hall, H. Irene;Song, Ruiguang;Rhodes, Philip;Prejean, Joseph;An, Qian;Lee, Lisa M.;Karon, John;Brookmeyer, Ron;Kaplan, Edward H.;McKenna, Matthew T.;Janssen, Robert S.
通讯作者：
Janssen, Robert S.